Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc <TTRX.OQ> expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc TTRX.OQ TTRX.O is expected to report resultson July 6 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Turn Therapeutics Inc is for a loss of 3 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Turn Therapeutics Inc is $6.15, about 13.6% below its last closing price of $7.12
This summary was machine generated July 3 at 11:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Turn Therapeutics
See all newsTurn Therapeutics Q2 net loss per share widens on higher R&D costs
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Turn Therapeutics Reports Interim Analysis Findings And Adaptive Optimization Strategy From Phase 2 GX-03 Trial In Moderate-To-Severe Atopic Dermatitis
Brief: Turn Therapeutics Reports First Quarter 2026 Financial Results